Bismarck News Updates

Global Saliva Glucose Biosensor Market will reach USD 179.71 million in 2027 – Credence Research

 Breaking News
  • No posts were found

Global Saliva Glucose Biosensor Market will reach USD 179.71 million in 2027 – Credence Research

August 31
20:42 2021
The latest market report published by Credence Research “Global Saliva Glucose Biosensor Market: Growth, Future Prospects, and Competitive Analysis, 2015 – 2027”. The Global Saliva Glucose Biosensor Market generated revenue of around USD 88.56 million in 2020 and is anticipated to grow at a CAGR of over 9.46% during the forecast period from 2021 to 2027 to reach around USD 179.71 million in 2027.

The latest market report published by Credence Research “Global Saliva Glucose Biosensor Market: Growth, Future Prospects, and Competitive Analysis, 2015 – 2027”. The Global Saliva Glucose Biosensor Market generated revenue of around USD 88.56 million in 2020 and is anticipated to grow at a CAGR of over 9.46% during the forecast period from 2021 to 2027 to reach around USD 179.71 million in 2027.

Global Saliva Glucose Biosensor Market, 2020 – 2027 (USD Million)

Browse the full report at (https://www.credenceresearch.com/report/saliva-glucose-biosensor-market )

Saliva Glucose Biosensor is an advanced ground breaking technology in the field of non-invasive glucose meters. Saliva Glucose Biosensor has revolutionized the glucose meters industry. Saliva Glucose Biosensor are developed with an intention to provide the diabetic patients with ultimate convenience and pain-free diabetes management. Saliva Glucose Biosensors are simple disposable units which when exposed to saliva provides accurate, real-time and quick diagnosis. Saliva Glucose Biosensor has offered diabetes patients and medical practitioners with a handy tool for the timely diagnosis of sugar level in diabetic patients. Saliva Glucose Biosensor are highly efficient and posses 100 times higher sensitivity as against blood glucose sensors. 

Ultimate Convenience to Patients

Saliva Glucose Biosensors are very handy and easy to use. They can be carried by patients while traveling as well. Saliva Glucose Biosensors are discrete and cost effective. Saliva Glucose Biosensors even facilitate remote monitoring of patients and manage their diabetes treatments accordingly. As Saliva Glucose Biosensors facilitate glucose measurement at home or while traveling as well, it effectively reduces the cost of visiting clinics and hospitals frequently. Secondly, Saliva Glucose Biosensors offers excellent feature of data tracking through mobile apps. This in turn offers entire data related to diabetic patients at one place and make it possible to manage diabetes in most effective way.

Growing Diabetic Population

Diabetic population growing day by day at a rapid pace. One of each ten adults are suffering from diabetes in the world. At present over 450 million people in the world are diabetic patients. The incidence rate is likely growth from around 9.7% at present to over 10.2% by the end of 2030. With rapid growth in diabetic patients, the demand for Saliva Glucose Biosensors is likely to go upward in the years to come.

Huge Growth Potential in Asia Pacific  

Asia Pacific is home to the largest population as well as largest diabetic people. Over 40% diabetic patients in the world are residing in the region. However, at present the demand for Saliva Glucose Biosensor in the region is less than North America and Europe. However, with growing income, rising awareness and increasing footprints of Saliva Glucose Biosensor manufacturers in the region the demand is anticipated to advance at a rapid pace over the span of analysis period. At present Asia Pacific held just around 20% share in the global Saliva Glucose Biosensor market. However, Asia Pacific is projected to exhibit fastest CAGR over the forecast period. North America dominated with over one third share in the global Saliva Glucose Biosensor market and followed by Europe at second place.

Focus on Distribution will Win the Market for Key Players

Major players have strong presence and strong distribution network in North America and Europe. At present, Asia Pacific market for Saliva Glucose Biosensor is in its nascent stage and poised to play critical role in the global Saliva Glucose Biosensor industry owing to increasing focus by the major players to extend their presence in the region. In a quest to win the market place in the region, major players are focusing on strengthening their distribution network in the region. China, and India are likely to offer tremendous growth opportunities to the industry participants. Major players operating in the global Saliva Glucose Biosensor market include iQ Group Global, Abbott, DexCom, Ascensia Diabetes Care, Senseonics, Parexel and GBS Inc.

Market Segmentation

Global Saliva Glucose Biosensor Market by Distribution Channel, 2015 – 2027

  • Online
  • Offline

Global Saliva Glucose Biosensor Market by End-user, 2015 – 2027

  • Hospitals
  • Home Care
  • Clinics

Global Saliva Glucose Biosensor Market by Company, 2015 – 2027

  • iQ Group Global
  • Abbott
  • DexCom
  • Ascensia Diabetes Care
  • Senseonics
  • Parexel
  • GBS Inc.   

Visit our blog: https://targetmarketsize.com/

Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: www.credenceresearch.com/report/saliva-glucose-biosensor-market


Warning: count(): Parameter must be an array or an object that implements Countable in /home/atlantanewsonlin/public_html/news.bismarcknewsupdates.com/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share

Categories